These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38525776)

  • 21. Randomized, double-blind trial evaluating the efficacy and safety of fluticasone propionate and fluticasone propionate/salmeterol delivered via multidose dry powder inhalers in patients with persistent asthma aged 12 years and older.
    Raphael G; Yiu G; Sakov A; Liu S; Caracta C
    J Asthma; 2018 Jun; 55(6):640-650. PubMed ID: 28763243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.
    Müller V; Gálffy G; Orosz M; Kováts Z; Odler B; Selroos O; Tamási L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():93-101. PubMed ID: 26834466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expanded table: Correct use of inhalers for asthma.
    Med Lett Drugs Ther; 2020 Dec; 62(1613):e204-e208. PubMed ID: 33446624
    [No Abstract]   [Full Text] [Related]  

  • 24. Dry-powder inhalers in acute asthma.
    Selroos O
    Ther Deliv; 2014 Jan; 5(1):69-81. PubMed ID: 24341818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levodopa inhalation powder in a patient with persistent asthma.
    Gillette C; Cooney JW; Sisson CB; Rockich-Winston N; Perry CJ; Moore WC
    Parkinsonism Relat Disord; 2020 Sep; 78():44-45. PubMed ID: 32702523
    [No Abstract]   [Full Text] [Related]  

  • 26. Misuse and/or treatment delivery failure of inhalers among patients with asthma or COPD: A review and recommendations for the conduct of future research.
    Mahon J; Fitzgerald A; Glanville J; Dekhuijzen R; Glatte J; Glanemann S; Torvinen S
    Respir Med; 2017 Aug; 129():98-116. PubMed ID: 28732842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asthma and chronic obstructive pulmonary disease inhalers: Techniques for proper use.
    Pepper AN; Cooke A; Livingston L; Lockey RF
    Allergy Asthma Proc; 2016 Jul; 37(4):279-90. PubMed ID: 27401315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Asthma medication delivery: mists and myths.
    Rottier BL; Rubin BK
    Paediatr Respir Rev; 2013 Jun; 14(2):112-8; quiz 118, 137-8. PubMed ID: 23522986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Impact of Inspiratory Flow Rate on Drug Delivery to the Lungs with Dry Powder Inhalers.
    Weers J; Clark A
    Pharm Res; 2017 Mar; 34(3):507-528. PubMed ID: 27738953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The dry powder inhaler features of the Easyhaler that benefit the management of patients.
    Chrystyn H; Lavorini F
    Expert Rev Respir Med; 2020 Apr; 14(4):345-351. PubMed ID: 32013627
    [No Abstract]   [Full Text] [Related]  

  • 31. Novel albuterol multidose dry powder inhaler in patients with exercise-induced bronchoconstriction: A single-dose, double-blind, randomized, 2-way crossover study.
    Ostrom NK; Taveras H; Iverson H; Pearlman DS
    Respir Med; 2015 Nov; 109(11):1410-5. PubMed ID: 26475054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of fluticasone propionate multidose, inhalation-driven, novel, dry powder inhaler versus a prevailing dry powder inhaler and a metered-dose inhaler.
    Gillespie M; Song S; Steinfeld J
    Allergy Asthma Proc; 2015; 36(5):365-71. PubMed ID: 26314817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of inhalers used in the treatment of respiratory diseases on global warming.
    Emeryk AW; Sosnowski T; Kupczyk M; Śliwiński P; Zajdel-Całkowska J; Zielonka TM; Mastalerz-Migas A
    Adv Respir Med; 2021; 89(4):427-438. PubMed ID: 34494246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Asthma patient satisfaction with different dry powder inhalers.
    Valero A; Ribó P; Maíz L; Barbero E; Calle M; Campo C; Rytilä P; Giner J; Plaza V
    Expert Rev Respir Med; 2019 Feb; 13(2):133-138. PubMed ID: 30625015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler.
    Prime D; de Backer W; Hamilton M; Cahn A; Preece A; Kelleher D; Baines A; Moore A; Brealey N; Moynihan J
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):486-97. PubMed ID: 26372467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics, Safety, and Tolerability of a New Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate Diskus(®) in Healthy Adults.
    Vutikullird AB; Gillespie M; Song S; Steinfeld J
    J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):207-14. PubMed ID: 26624976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding Dry Powder Inhalers: Key Technical and Patient Preference Attributes.
    Levy ML; Carroll W; Izquierdo Alonso JL; Keller C; Lavorini F; Lehtimäki L
    Adv Ther; 2019 Oct; 36(10):2547-2557. PubMed ID: 31478131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Inhalation therapy without instruction: failure foreseen].
    Burgos F
    Arch Bronconeumol; 2002 Jul; 38(7):297-9. PubMed ID: 12199927
    [No Abstract]   [Full Text] [Related]  

  • 39. Bronchodilator Efficacy of a Single-Dose 12/400-µg Formoterol/Budesonide Combination as a Dry Powder for Inhalation Delivered by Discair
    Yildiz P; Bayraktaroglu M; Gorgun D; Yuksel K
    Clin Drug Investig; 2019 Oct; 39(10):991-1001. PubMed ID: 31332649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Inhalers and nebulizers in the children].
    David V; Mély L; Siret D; Dubus JC
    Arch Pediatr; 2002 Aug; 9 Suppl 3():415s-421s. PubMed ID: 12205818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.